Roka BioScience, Inc. (ROKA) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 121 transactions totaling $60.7M, demonstrating a bullish sentiment with $59.2M in net insider flow. The most recent transaction on Oct 3, 2017 involved a sale of 1,899 shares valued at $1.3K.
No significant insider buying has been recorded for ROKA in the recent period.
No significant insider selling has been recorded for ROKA in the recent period.
Based on recent SEC filings, insider sentiment for ROKA is bullish with an Insider Alignment Score of 99/100 and a net flow of $59.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Roka BioScience, Inc. (ROKA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading ROKA stock, having executed 121 transactions in the past 90 days. The most active insider is Advisors Llc Orbimed (Executive), who has made 16 transactions totaling $4.7M.
Get notified when executives and directors at ROKA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 3, 2017 | Gp III Llc Orbimed Capital | Executive | Sale | 1,899 | $0.68 | $1.3K | |
| Oct 3, 2017 | Gp III Llc Orbimed Capital | Executive | Sale | 199,718 | $0.68 | $135.8K | |
| Sep 29, 2017 | Gp III Llc Orbimed Capital | Executive | Sale | 93,246 | $0.74 | $69.0K | |
| Sep 29, 2017 | Gp III Llc Orbimed Capital | Executive | Sale | 888 | $0.74 | $657 | |
| Sep 28, 2017 | Gp III Llc Orbimed Capital | Executive | Sale | 376,950 | $0.72 | $271.4K | |
| Sep 28, 2017 | Gp III Llc Orbimed Capital | Executive | Sale | 3,592 | $0.72 | $2.6K | |
| Sep 27, 2017 | D. Isaly Samuel | Executive | Sale | 498 | $0.92 | $458 | |
| Sep 27, 2017 | D. Isaly Samuel | Executive | Sale | 52,301 | $0.92 | $48.1K | |
| Sep 26, 2017 | D. Isaly Samuel | Executive | Sale | 74,096 | $1.03 | $76.3K | |
| Sep 26, 2017 | D. Isaly Samuel | Executive | Sale | 706 | $1.03 | $727 | |
| Aug 24, 2017 | Gp III Llc Orbimed Capital | Executive | Sale | 125 | $1.50 | $188 | |
| Aug 24, 2017 | Gp III Llc Orbimed Capital | Executive | Sale | 13,075 | $1.50 | $19.6K | |
| Aug 23, 2017 | Gp III Llc Orbimed Capital | Executive | Sale | 10 | $1.50 | $15 | |
| Aug 23, 2017 | Gp III Llc Orbimed Capital | Executive | Sale | 1,090 | $1.50 | $1.6K | |
| Aug 22, 2017 | Llc Orbimed Advisors | Executive | Sale | 52 | $1.52 | $79 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 18 | $60.0M | 98.5% |
Sale(S) | 20 | $742.2K | 1.2% |
Conversion(C) | 66 | $135.0K | 0.2% |
Payment(F) | 15 | $26.5K | 0.0% |
Award(A) | 2 | $0 | 0.0% |
Insiders at Roka BioScience, Inc. are accumulating shares at an accelerated pace. With 25 insiders making 121 transactions totaling $60.0M in purchases versus $742.2K in sales, the net buying activity of $59.2M signals strong executive confidence. Advisors Llc Orbimed (Executive) leads the buying activity with $4.7M in transactions across all time.